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INTRODUCTION 
 Acute Severe Myocardial Dysfunction Contributes A Significant 
Cause Of Mortality And Morbidity In Critically Ill Children Admitted In 
Picu. Severity assessment of illness and outcome in critically ill children is 
important as it influences management strategies and resource allocation. 
This Prospective Study Aims To Evaluate Myocardial Status In Critically Ill 
Children Admitted In Picu Using CARDIAC TROPONIN T cTnT Levels 
As  Early Determinant Of Myocardial Injury along with ECHO,ECG As 
Diagnostic Tools. 
 
 In Picu Admitted Children There Are Physiological Stresses In Form 
Of Sepsis, Hypoxia Resulting In Cardiac Dysfunction, Injury And Also 
Both. This Injury Is contributed by increased myocardial oxygen demands 
and decreased myocardial oxygen supply. ECG is  very much important for 
this study as it shows myocardial ischemia and shows ECG patterns of T 
wave inversion, ST elevation, Prominence of Q wave, R wave reduction due 
to necrosis. TROPONIN T was measured at admission while drawing 
routine blood samples in PICU. On the same day of admission 
echocardiogram was performed bedside by Paediatric cardiologist. ECHO 
determines  LVEF-left ventricular ejection fraction, systolic fraction 
shortening, Dilated Cardiomyopathy, Thinned out Ventricles, ventricular 
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dysfunction. CHEST XRAY was taken bedside .CXR contributes valuable 
information on Heart and Lung pathology. 
 
 The aim of our study was to evaluate myocardial status in critically ill 
children admitted in PICU and to assess the relation between CARDIAC 
TROPONIN T cTnT levels and disease severity and duration of PICU stay, 
mortality with myocardial dysfunction measured by 
ECHOCARDIOGRAPHY. 
 
MYOCARDIAL INJURY 
PATHOPHYSIOLOGY 
 The myocardium may be affected in several ways in critically ill 
children in PICU. There is disparity between myocardial oxygen demand 
and supply. Myocardial ischemia, myocyte death may occur directly due to 
stress factors imposed on heart due to several non-cardiac etiology such as 
Hypoxia, shock, sepsis, Acute kidney injury, MODS, electrolyte 
abnormalities, hypovolemia, anemia, hypertension, post surgery, drugs, 
toxins released due to viral and other underlying infections. Second phase 
there is direct myocyte death due to direct effects and also activation of 
innate immune response which contributes to further myocardial 
damage.Third phase the antibodies released by viral specific responses 
continue to damage myocardium resulting in dilated cardiomyopathy in a 
genetically predisposed individual.myocardial damage results in contractile 
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dysfunction and ventricular dilatation.papillary muscle dysfunction can 
cause valvular regurgitation. pericardial effusion can also occur. 
 
CARDIAC FINDINGS IN CRITICALLY ILL CHILDREN 
MYOCARDIAL ISCHEMIA: 
 Myocardial ischemia is caused by decreased oxygen supply-“primary 
ischemia” or increased demand-“secondary ischemia” or a combination of 
two-“combined ischemia”. The sum of all may result in a cascade of events 
constitutes the total ischemic burden. This directly reflects in systolic 
dysfunction resulting in fall in “LVEF”. TROPONIN-T levels are elevated 
representing myocardial damage. ECG shows ST Depression and T Wave 
Inversion. Echocardiogram shows decreased left ventricular contraction or 
fractional shortening. 
 
DILATED CARDIOMYOPATHY 
 Dilated cardiomyopathy characterised by cardiac dilatation, 
diminished cardiac contractility, congestive cardiac failure. It is also 
characterised by fractional shortening, LVEF decrease and mitral and 
tricuspid valve regurgitation. Despite of fall in LVEF cardiac output is 
maintained by tachycardia. Tachycardia of any etiology increases 
myocardial oxygen demand owing to reduced filling time, reducing the 
coronary perfusion. pulmonary edema may develop and cardiac output gets 
diminished. Myocarditis can present in acute or chronic manner. Chronic 
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myocardial damage in form of ongoing myocarditis, accelerated coronary 
artery disease, cachexia, drug toxicity all can contribute to dilated 
cardiomyopathy. 
 
 Anemia, viral or any infections, hypoxia, ischemia, acidosis, 
hypercarbia, hyperthermia, hypocalcemia contributes to myocardial 
dysfunction. Treatment consists of correction of co-existent metabolic 
abnormalities, supporting of myocardium with intravenous fluids and 
ionotropic agents like Dopamine, Dobutamine, adrenaline, milrinone. 
 
CARDIAC DYSRHYTHMIAS 
 Tachycardia, ventricular fibrillation, bradycardia, sinus node arrest  
manifestations are found in critically ill children. 
 
PERICARDIAL EFFUSION 
 Pericardial effusion is commonly seen in HIV patients, 
Hypothyroidism, Autoimmune diseases, chronic kidney disease, Kaposi 
sarcoma. Bacterial, viral, fungal infections also cause pericarditis. Clinically 
children may present with dyspnoea or chest pain. There is muffling of heart 
sounds on auscultation. CXR shows flask shaped heart. ECG shows low 
voltage QRS complexes. Echocardiography detects pericardial effusion. 
Large pericardial effusion with cardiac tamponade can also occur in 
mycobacterium infection. 
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PULMONARY HYPERTENSION 
 Pulmonary hypertension can occur in HIV, chronic kidney disease, 
Recurrent pneumonia, sickle cell disease, autoimmune disorder, vasculitis. 
Right heart failure secondary to severe pulmonary hypertension is also a 
possibility. Right ventricular function should be assessed with modalities 
such as tissue Doppler echocardiography and tricuspid regurgitation 
mapping. 
 
MITRAL REGURGITATION, TRICUSPID REGURGITATION-
VALVULAR INVOLVEMENT 
 Mitral regurgitation, tricuspid regurgitation  can occur in Dilated 
cardiomyopathy. Valvular involvement is confirmed with echocardiogram. 
Myocardial damage results in myocardial dysfunction. Ventricular 
dilatation, papillary muscle dysfunction can cause valvular regurgitation.  
2D ECHOCARDIOGRAPHY - identifies the pattern of valvular 
involvement. Colour Doppler imaging assesses regurgitation or 
stenosis.Spectral Doppler to assess gradient across cardiac valves.Non 
bacterial thrombotic endocarditis can occur in SLE,HIV. 
 
RESTRICTIVE CARDIOMYOPATHY 
 Myocardial fibrosis, endocardial fibrosis leads to restrictive 
cardiomyopathy. It is observed in children on anticancer drugs 
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VENTRICULAR HYPERTROPHY 
 Left ventricular hypertrophy from systemic hypertension 
 Right ventricular hypertrophy from pulmonary hypertension 
 Left ventricular hypertrophy occurs in chronic kidney disease due to 
volume overload and pressure overload. left ventricular hypertrophy 
is also observed in Metabolic syndrome, HIV children 
 
CORONARY ARTERY INVOLVEMENT 
 Children can be affected with early coronary artery disease in HIV, 
Metabolic syndrome, Vasculitis in ECHO-regional wall motion 
abnormalities should be assessed for accelerated coronary artery disease. 
 
LARGE VESSEL ARTERIOPATHY 
 Arteriopathy of aorta and pulmonary arteries observed in HIV 
children. Characterised by medial hypertrophy and chronic inflammation 
and stenosis of vessels 
 
INTRACARDIAC  MASSES 
 Kaposi sarcoma, non-hodgkin lymphoma are malignancies that 
primarily involve myocardium or pericardium. Secondary metastasis to 
heart is rare. 
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CONGESTIVE CARDIAC FAILURE 
 Myocardial ischemia, myocyte death leads to primary myocardial 
dysfunction contributes to congestive cardiac failure 
 
CARDIAC TROPONIN  
 Cardiac troponin T and I  are regulatory proteins found on the 
contractile apparatus of striated muscle that controls calcium mediated 
interaction of actin and myosin. Specific forms of troponin subunits T,C,I 
exist in different muscle types. Since troponins do not occur in extracellular 
space their appearance in serum is sensitive and specific marker of 
myocardial damage. Cardiac troponin starts rising in the serum 2-4 hours 
after myocardial injury, peaks at 48 hours and remains elevated for 7-10 
days. Normal values of troponin 0 to 0.097 microgram / L.cardiac specific 
troponins have T and I have become established as gold standard 
biochemical markers for myocardial necrosis .elevated troponin is a 
common finding in critically ill patients in ICU. Frequent conditions causing 
troponin elevation include hypovolemia, sepsis, heart failure, demand 
ischemia, tachycardia, heart failure, myocarditis, myocardial contusion, 
COPD, pulmonary hypertension, pulmonary embolus and renal failure. 
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 Ammann and colleagues reported in 85% of 20 ICU patients with 
sepsis had elevated troponin levels 59% had no underlying coronary artery 
disease. 
 
 Bakshi and colleagues showed tachycardia, demand ischemia, 
tachyarrythmia, pericarditis, strenuous exercise, ccf, supraventricular 
tachycardia cause elevated troponin T levels in ICU. 
 
 Hamwi and colleagues reported in 74 patients without no evidence of 
myocardial ischemia, LVH patients had raised troponin T levels 
 
 Ramappa and colleagues showed higher mortality in subarachnoid 
hemorrhage patients with elevated troponin T levels. 
 
 Brunet and colleagues 27% of raised troponin T in chronic kidney 
disease patients on hemodialysis. 
 
 Hsu and colleagues increase in mortality rate in elevated troponin T 
patients with right ventricular hypertrophy 
  
 9   
 
 
 
 
Elevation of enzymes after myocardial infarction  
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ECHOCARDIOGRAPHY 
 Echocardiography is a major non-invasive cardiac investigation first 
demonstrated by edler. The frequency of ultrasound waves is greater than 
that appreciated by human ears(18-20 kilohertz) 
 
 Ultrasound are generated by materials that have piezoelectric effect. 
They have the ability to emit sound waves and receive them to generate a 
potential. The sound source of a transducer is a circular lead zirconate 
titanate crystal that ranges from 6-13 mm in diameter. The transducer is 
activated to about 3000 times/sec to emit ultrasound pulses. 
 
 The sound waves are reflected when it encounters a boundary 
between two materials of different physical properties such as blood, 
endocardium. 
 
Types of echocardiogram: 
There are three methods of echocardiogram 
1. M - Mode 
2. Two Dimensional (2-D) or Cross Sectional 
3. Doppler - Continuous Wave, Pulsed Wave and Colour Flow. 
\ 
M MODE (Motion mode) 
 High sensitivity of moving structures 
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 Useful in valve motion, measurement of the size and thickness of 
cardiac chambers. 
 
Two Dimensional 2 D or Cross Sectional 
a) Parasternal view 
b) Apical four chamber view 
c) Subcostal view 
d) Suprasternal view  
 
DOPPLER ECHO 
 Gives hemodynamic information regarding heart and blood vessels.it 
can be used to measure severity of valvular narrowing(stenosis),valvular 
leakage (regurgitation) and shunts like VSD,ASD 
 
Summary of Echo Modalities and their main uses 
 
2-D Echo Anatomy, Ventricular and valvular movements, 
positioning for M Mode and Doppler Echo. 
M-mode Echo Measurement of dimensions, timing of cardiac 
events. 
Pulsed Wave Doppler Normal valve flow patterns, LV diastolic function, 
stroke volume and cardiac output  
Continuous wave Severity of valvular stenosis, severity of valvular 
lesions 
Doppler Regurgitation  
Velocity of flow in shunts 
Colour flow mapping Assessment of regurgitation and shunts 
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Usefulness of Normal Echo 
Echo provides a great deal of anatomical and haemodynamic information:  
 Heart chamber size 
 Chamber function (systolic and diastolic) 
 Valvular motion and function 
 Intracardiac and extracardiac masses and fluid collections 
 Directing blood flow and haemodynamic information 
 
Objective Method 
Assess pericardial effusion 2D echocardiography 
Systolic and diastolic function Measure left ventricular ejection 
fraction or fractional shortening 
Calculate myocardial performance 
index 
Tissue Doppler interrogation of 
mitral and tricuspid valve annuli  
Pulsed-wave Doppler interrogation 
of pulmonary veins and mitral inflow 
Measure tricuspid annulus plane 
systolic excursion 
Quantify global ventricular systolic 
function by deformation imaging 
Quantify regional wall motion 
abnormality by deformation imaging 
Assess for endocardial disease 
Non-bacteria thrombotic (verrucous, 
Libman-Sacks) endocarditis 
Valve predilection: mitral >aortic 
>tricuspid > pulmonary 
Mural endocarditis 
Rheumatoid nodules in rheumatoid 
arthritis 
 
2D echocardiography 
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Assess hemodynamic characteristics 
Pulmonary hypertension 
Estimate right ventricular systolic 
pressure by Doppler interrogation of 
tricuspid regurgitation 
 
Assess secondary effects on heart 
Left ventricular hypertrophy from 
systemic hypertension 
Right ventricular hypertrophy from 
pulmonary hypertension 
Assess diastolic function of the 
ventricles 
Measure left ventricular septal and 
posterior wall thickness 
Calculate left ventricular mass 
 
 
 
 
 The four basic image planes used in transthoracic echocardiography. 
Four chamber view includes both ventricles and both atria. 
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Transducer motion for echocardiography in left parasternal transducer 
position. 
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 Normal parasternal long-axis 2D echo images at end-diastole left and 
end-systole. 
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ECG CHANGES 
 ECG is an important investigation to diagnose the various diseases 
affecting the cardiovascular system. 
 
Classification of Leads  
The leads are broadly classified into frontal plane and horizontal leads. 
1) Frontal plane leads : L1, LII, LIII, aVR, aVL, aVF 
2) Horizontal leads : V1, V2, V3, V4, V5, V6 
 
 Leads are also classified into bipolar leads (LI, LII and LIII) and 
unipolar leads (aVR, aVL, aVF, chest leads V1 to V6 and oesophageal leads) 
 
Analysis 
Analysis of the ECG consists of : 
1. Identification of position of the heart 
2. Rhythm 
3. Rate 
4. P wave abnormalities 
5. Identification of axis, and 
6. Ventricular hypertrophic pattern 
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ECG changes in  Myocardial Infarction 
 The infarct is pyramid shaped with a broad base towards the 
endocardium. It also shows the necrosis, injury and ischaemia are in 
quotation marks. The broad ECG changes are as follows: 
1. Prominence of the Q wave 
2. Reduction of ‘R’ wave due to necrosis 
3. ST segment elevation and T wave inversion 
 
Ischaemia : The early changes are ST segment depression and symmetrical 
T-wave inversion. 
 
Injury : ST segment elevation with convexity upwards. 
 
Necrosis: Q wave appears with ST segment elevation and T wave inversion 
seen. The amplitude of R wave is decreased. 
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(A) Normal ECG, (B) ST elevation with acute ischemia,   
(C) Q-wave with acute myocardial infarction, (D) ST segment depression 
(E) ST elevation 
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CHEST X-RAY 
 Chest X-Ray is an important, cost effective and simple investigation 
to diagnose the various diseases affecting the heart and lungs. 
 
 
 
 During neonatal period the cardiothoracic ratio upto 70% is normal. 
In adults, the normal cardiothoracic ratio is 44%. 
 
 Cardiomegaly can be considered if the cardiothoracic ratio is 
exceeding 0.5 in adults and 0.6 in children. 
  
Aims & Objectives 
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AIMS AND OBJECTIVES 
 
 To assess myocardial status in critically ill children admitted in PICU, 
Paediatric Intensive Care Unit, Stanley Medical College Hospital. using 
Quantitative Method Troponin T (cTNT) levels, bed side Echo Cardiogram,  
ECG and Chest X-Ray. 
 
Primary Objective: 
• To evaluate myocardial status in critically ill children in PICU to 
assess the relation between Cardiac Troponin T levels and disease 
severity with myocardial dysfunction measured by bedside 
Echocardiography.  
 
Secondary Objective:  
To analyse the clinical outcome of myocardial injury in non cardiac cases in 
terms of 
• Need for ionotropic support 
• Need for ventilator support 
• Length of hospital stay 
• Mortality  
  
Review of Literature 
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REVIEW OF LITERATURE 
 
SJ CLARK ET AL 
 Clark et all studied the role of Troponin-T in critically ill children 
admitted in PICU without congenital heart disease. They studied 107 infants 
out of which 47 were PICU,60 healthy controls. The median (IQR) of cTnT 
levels in PICU and control group infants were 18(10-60 pg/ml) and 10, 
(p<0.001).they found out a positive correlation  between cTnT levels and 
paediatric index of mortality score (r=0.41,p=0.004). They concluded that 
neonates have higher troponin T levels when compared to infants above  
1 year despite not having severe disease. 
 
KEFENTON ET AL 
 Fenton et al studied the increase in serum levels of troponin I 
associated with cardiac dysfunction and disease severity in pediatric patients 
with septic shock. Serial troponin i was studied in 23 children with septic 
shock during admission and after 72 hours. Echo was perfomed to analyse 
cardiac dysfunction. PIM score was obtained. Troponin-I elevation was 
associated with cardiac dysfunction and correlated with severity of illness. 
Troponin-I was increased in >50% of children with septic shock. 
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RAJAKUMAR  ET AL 
 Rajakumar et al studied myocardial damage in neonates. He 
performed a case control study of 30 term neonates(cases) with perinatal 
asphyxia and 30 term neonates without asphyxia(control).23 babies in cases 
group had myocardial injury when compared to 1 in control group.mean 
serum troponin T was 0.22+/-0.28 in cases and in control group 0.003+/-
0.018 .cardiac troponin t had better specificity and sensitivity in evaluating 
cardiac dysfunction and also correlated with disease severity and outcome.  
 
BASHEIR HASSAN ET AL  
 The study aimed at investigating the occurrence of myocardial injury 
in critically ill children through troponin t levels and assessment of disease 
severity and supported by cardiac dysfunction assessed by 
echocardiography.it was a 6 month study of case control type of 50 patients 
in PICU of zagazig university Egypt.25 healthy controls were included. 
Cardiac troponin t levels were significantly higher in critically ill children 
median 22(18-28) in comparison to healthy children median (10 pg/l, 
p<0.05) cardiac troponin t levels correlated positively with disease severity 
negative correlation with ejection fraction. There was a statistically 
significant positive correlation between mortality and high troponin t levels. 
Elevated troponin t levels were associated with increased duration of 
ventilation and disease severity. 
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THIRU Y PATHAN ET AL 
 The study aimed in analyzing myocardial cytotoxic process involved 
in cardiac dysfunction of meningococcal septic shock. They studied release 
of troponin I a marker of myocardial cell death and related this to disease 
severity and cardiac dysfunction.it was a prospective study done in PICU in 
patients with meningococcal septicemia. Serum troponin I was measured in 
101 children with meningococcal septicemia and serially in 37 children. 
PIM score was assessed.62%of patients had elevated Troponin-I. 
Myocardial depression was measured by echocardiogram. Significant 
positive correlation was observed in troponin I levels and disease severity. 
 
KLEIN GUNNEWIEK ET AL 
 This study conducted in ICU aimed to determine the incidence of 
troponin t elevations in critically ill patients and correlating these findings 
with electrocardiogram and to compare the troponin t patients with troponin 
t negative patients by clinical parameters.34 patients were studied. Blood 
samples for troponin t  were collected during admission and after 24 
hours.11 out of 34(73%) had elevated Troponin-T levels. Significantly 
p=0.0055 troponin t patients underwent surgery and more significantly 
p=0.0045 patients suffered from hypotension. There was a positive 
correlation in critically ill patients and elevated troponin t levels 
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EISENHUT ET AL 
 The study aimed at determining the prevalence of myocardial damage 
in RSV (respiratory syncytial virus infection) evident from elevated 
Troponin T levels. The study was done in PICU –royal Liverpool children’s 
hospital.34 children were studied,12(35%) had elevated Troponin T levels. 
The extent of myocardial damage were supported by ECG, ECHO findings. 
The children with elevated troponin t had hypotension during admission. 
The study concluded that myocardial damage was common in infants with 
severe RSV infection without congenital heart disease. Troponin T elevation 
was associated with hypotension. 
 
J .P QUENOT ET AL 
 The study aimed at relation between myocardial injury assessed by 
Troponin I levels and outcome in critically ill patients without acute 
coronary syndromes or cardiac dysfunction.it was a prospective study in 
ICU. 217 patients were studied.32%( 69 of 217) had elevated levels. Overall 
mortality was 27%(58 of217).patients with myocardial injury had a 
mortality rate of 51% compared to 16% of those without myocardial injury. 
Elevated troponin levels were associated with increased hospital 
mortality(p=0.01) 
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C.SPIES ET AL 
 The study objective was to investigate Troponin T as an early marker 
of myocardial injury and a prognostic marker of early sepsis.it was a 
prospective study in surgical ICU.26 patients were included in the study.18 
patients had elevated troponin t levels.15 out of 18 expired. High Troponin 
T values were associated with increased mortality rate 
 
AMMANN ET AL 
 This study was analysed in 58 critically ill patients other than acute 
coronary syndrome according to their troponin  status. Mortality, LVEF 
were compared in two groups of troponin positive and negative patients. 
Among 58 patients,32(55%) were troponin positive. Positive troponin levels 
were associated with higher mortality(22.4% vs 5.2%,p <0.018) and lower 
LVEF(p=0.0006)troponin positive patients had significantly higher median 
levels of TNF-ALPHA AND INTERLEUKIN 6. 
 
G.BRIASSOULIS ET AL 
The study was done to assess the incidence of myocardial ischemia in 
meningococcus induced purpura fulminans in children and to compare 
troponin levels with ECG changes.22 patients were studied. Serial troponin 
levels, ECHO, ECG was done in them.5 children had myocardial ischemia, 
4 of them died.  
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ECG ischemic changes was associated with high levels of troponin 
(1.93+/-0.13 vs 0.18+/-0.08 ng/ml,p<0.001) and low LVEF in ECHO. 
Incidence of myocardial ischemia is higher in meningococcus induced 
purpura fulminans children.   
  
Materials & Methods 
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MATERIALS AND METHODS 
 
Study Place : 
 Pediatric Intensive Care Unit, Institute of Social Pediatrics govt. 
Stanley Medical College & Hospital, Chennai-1. 
 
Study Duration : 01.04.2017 - 30.9.2017 
Study Population : Critically ill children admitted in PICU 
Study Design : Hospital based Prospective Observational Study 
Sample Size  : 112 
 
Inclusion Criteria: 
1. Children admitted in PICU from age  1month-12 years. 
2. Children with no pre-existing cardiac illness both acquired & 
congenital 
 
Exclusion Criteria: 
1. Neonates 
2. Children with pre-existing congenital &acquired cardiac illness 
3. Post Cardiac Arrest Resuscitation                                       
4. If parents have not given consent 
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Study Protocol 
 Ethical Committee Clearance was obtained to conduct the study in 
our PICU unit in our hospital. Informed written consent was obtained to 
conduct the study in our hospital from parents and caregivers before 
including the children in our study. There was no added harm or risk to the 
child because of the study. 
 
Sample Collection and Analysis 
 A detailed history and clinical examination was done for children 
admitted in PICU fulfilling the inclusion criteria. 
 
 CARDIAC TROPONIN(cTnT) in blood was measured on the time of 
admission in these children. sample was obtained during routine venous 
access.cardiac troponin was measured in lab using ECLIA method-
electrochemiluminescent sandwich enzyme linked immunosorbant assay 
(ROCHE KIT)has a lower limit of detection value. Values above 0.1ng/ml 
was taken as positive. 
 
 12 lead ECG was recorded on day of admission and was magnified 
100% and photocopied for study 
 
 Two dimensional M MODE echocardiography was performed 
bedside by Pediatric cardiologist on the day of admission to identify cardiac 
abnormalities on these children. It is performed with bedside echo machine 
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GE 2012 model. Right ventricular hypokinesia and left ventricular 
hypokinesia supported by low ejection fraction (EF), pulmonary 
hypertension and right atrial / right ventricle dilatation. Normal ejection 
fraction 55-75%. 
 
 Primary outcome and secondary outcome were studied in these 
children system wise and illness wise.  
 
 The diagnostic modalities like TROPONIN T, ECHO, ECG were 
evaluated for sensitivity and specificity in comparison with clinical 
diagnosis of myocardial injury. 
 
STATISTICAL  ANALYSIS 
 The collected data were analysed with IBM.SPSS statistics   software 
23.0 version to describe about the data descriptive statistics, frequency 
analysis, percentage analysis were used for  categorical variables and the 
Mean and SD were used for continuous variables.to find the significant 
difference between  the bivariate samples in independent groups the 
unpaired  sample t test was used.to find significance in categorical data  chi-
square test was used. Similarly if the expected  cell  frequency is less than 5 
in 2x2 tables then the fischer’s Exact  was used.in all the above statistical 
tools the probability value  0.05 is considered as significant level.   
  
Observation & Results 
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OBSERVATION AND RESULTS 
 
GENDER WISE DISTRIBUTION 
 Normal Positive 
Female 50.6% 42.4% 
Male 49.4% 57.6% 
 
 
Groups 
Total 
Normal Positive 
Gender 
Female 
Count 40 14 54 
% within 
Groups 50.6% 42.4% 48.2% 
Male 
Count 39 19 58 
% within 
Groups 49.4% 57.6% 51.8% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square .628a 1 .428   
Continuity 
Correction .342 1 .558   
Likelihood 
Ratio .630 1 .427   
Fisher's 
Exact Test    .535 .280 
N of Valid 
Cases 112     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
15.91.   b. Computed only for a 2x2 table 
 
Among total of 112 children, male 58 children (51.8%), female were 54 children 
(48.2%). Troponin –T positive children, female were 42.4%, male 57.5%. 
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AGE WISE DISTRIBUTION  
 Normal Positive 
Upto 6 Months 22.8% 33.3% 
> 6 - 1 yr 13.9% 12.1% 
> 1 - 5 yrs 27.8% 33.3% 
6 - 10 yrs 16.5% 15.2% 
> 10 yrs 19.0% 6.1% 
 
 
Groups 
Total 
Normal Positive 
Age 
Upto 6 
Months 
Count 18 11 29 
% within 
Groups 22.8% 33.3% 25.9% 
> 6 - 1 yr 
Count 11 4 15 
% within 
Groups 13.9% 12.1% 13.4% 
> 1 - 5 yrs 
Count 22 11 33 
% within 
Groups 27.8% 33.3% 29.5% 
6 - 10 yrs 
Count 13 5 18 
% within 
Groups 16.5% 15.2% 16.1% 
> 10 yrs 
Count 15 2 17 
% within 
Groups 19.0% 6.1% 15.2% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 3.882a 4 .422 
Likelihood Ratio 4.313 4 .365 
Linear-by-Linear 
Association 2.617 1 .106 
N of Valid Cases 112   
1 cells (10.0%) have expected count less than 5.  
The minimum expected count is 4.42. 
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DISEASES AND OUTCOME 
 Negative Positive 
CNS 82.8% 17.2% 
CVS 0.0% 100.0% 
GIT 77.8% 22.2% 
IEM 33.3% 66.7% 
RS 66.7% 33.3% 
SEPSIS 57.1% 42.9% 
 
DISEASES * OUTCOME Cross tabulation 
 
OUTCOME Total N P 
DISEASES 
CNS 
Count 24 5 29 
% within 
DISEASES 82.8% 17.2% 100.0% 
CVS 
Count 0 3 3 
% within 
DISEASES 0.0% 100.0% 100.0% 
GIT 
Count 7 2 9 
% within 
DISEASES 77.8% 22.2% 100.0% 
IEM 
Count 1 2 3 
% within 
DISEASES 33.3% 66.7% 100.0% 
RS 
Count 24 12 36 
% within 
DISEASES 66.7% 33.3% 100.0% 
SEPSIS 
Count 4 3 7 
% within 
DISEASES 57.1% 42.9% 100.0% 
Total 
Count 60 27 87 
% within 
DISEASES 69.0% 31.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 11.897a 5 .036 
Likelihood Ratio 12.366 5 .030 
N of Valid Cases 87   
a. 7 cells (58.3%) have expected count less than 5. The minimum expected count 
is .93. 
 
 87 children with diseases in predominant major system have been analysed 
in detail for their positive correlation, negative correlation and prevalence of 
cardiac dysfunction. There is a statistically positive significance of p value = 
0.036 for major systems CNS, CVS, GIT, IEM, RS and Sepsis. 
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STUDY POPULATION WITH ECHO CARDIOGRAM 
CHANGES 
 Normal Positive 
Abnormal 0.0% 39.4% 
Normal 100.0% 60.6% 
 
Crosstab 
 
Groups 
Total 
Normal Positive 
Echo 
Abnormal 
Count 0 13 13 
% within 
Groups 0.0% 39.4% 11.6% 
Normal 
Count 79 20 99 
% within 
Groups 100.0% 60.6% 88.4% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 35.208a 1 .000   
Continuity 
Correctionb 31.473 1 .000   
Likelihood Ratio 36.170 1 .000   
Fisher's Exact 
Test    .0005 .000 
N of Valid Cases 112     
a. 1 cells (25.0%) have expected count less than 5. The minimum expected count is 
3.83.    b. Computed only for a 2x2 table 
 
 There is a statistically significant p value = 0.0005 of cardiac dysfunction 
(Troponin-T positivity and Positive Echo findings). 
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STUDY POPULATION WITH ECG 
 
 Normal Positive 
Abnormal 29.1% 60.6% 
Normal 70.9% 39.4% 
 
Crosstab 
 
Groups 
Total 
Normal Positive 
ECG 
Abnormal 
Count 23 20 43 
% within 
Groups 29.1% 60.6% 38.4% 
Normal 
Count 56 13 69 
% within 
Groups 70.9% 39.4% 61.6% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square 9.760a 1 .002   
Continuity 
Correctionb 8.474 1 .004   
Likelihood Ratio 9.622 1 .002   
Fisher's Exact 
Test    .003 .002 
N of Valid Cases 112     
a. 0 cells (.0%) have expected count less than 5.  The minimum expected  
count is 12.67.     b. Computed only for a 2x2 table 
 
 
 There is a statistically significant p value = 0.002 of cardiac dysfunction 
(Troponin-T positivity and Positive ECG findings). 
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STUDY POPULATION WITH CHEST-XRAY CHANGES 
 
 Normal Positive 
Abnormal 35.4% 60.6% 
Normal 64.6% 39.4% 
  
 
Groups 
Total 
Normal Positive 
Chest X-
ray 
Abnormal 
Count 28 20 48 
% within 
Groups 35.4% 60.6% 42.9% 
Normal 
Count 51 13 64 
% within 
Groups 64.6% 39.4% 57.1% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square 6.018a 1 .014   
Continuity 
Correctionb 5.035 1 .025   
Likelihood Ratio 5.997 1 .014   
Fisher's Exact 
Test    .021 .013 
N of Valid Cases 112     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
14.14. 
b. Computed only for a 2x2 table 
 
 There is a statistically significant p value = 0.014 of cardiac dysfunction 
(Troponin-T positivity and Positive Chest X-Ray findings).  
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PRIMARY OUTCOME 
 
 Normal Positive 
Non Survivor 15.2% 78.8% 
Survivor 84.8% 21.2% 
 
 
Groups 
Total 
Normal Positive 
Mortality 
Non 
Survivor 
Count 12 26 38 
% within 
Groups 15.2% 78.8% 33.9% 
Survivor 
Count 67 7 74 
% within 
Groups 84.8% 21.2% 66.1% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 41.998a 1 .0005   
Continuity 
Correctionb 39.209 1 .000   
Likelihood Ratio 42.074 1 .000   
Fisher's Exact 
Test    .000 .000 
N of Valid 
Cases 112     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
11.20. 
b. Computed only for a 2x2 table 
 
 The difference between mortality among Troponin-T positive and negative 
children was statistically significant p value = 0.0005 was evident by Pearson Chi-
Square test. 
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AGE WITH MORTALITY 
 Non Survivor Survivor 
Upto 6 Months 34.5% 65.5% 
> 6 - 1 yr 40.0% 60.0% 
> 1 - 5 yrs 36.4% 63.6% 
6 - 10 yrs 38.9% 61.1% 
> 10 yrs 17.6% 82.4% 
 
Age * Mortality Cross tabulation 
 
Mortality 
Total Non 
Survivor Survivor 
Age 
Upto 6 
Months 
Count 10 19 29 
% within 
Age 34.5% 65.5% 100.0% 
> 6 - 1 yr 
Count 6 9 15 
% within 
Age 40.0% 60.0% 100.0% 
> 1 - 5 yrs 
Count 12 21 33 
% within 
Age 36.4% 63.6% 100.0% 
6 - 10 yrs 
Count 7 11 18 
% within 
Age 38.9% 61.1% 100.0% 
> 10 yrs 
Count 3 14 17 
% within 
Age 17.6% 82.4% 100.0% 
Total 
Count 38 74 112 
% within 
Age 33.9% 66.1% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. Sig.  
(2-sided) 
Pearson Chi-Square 2.546a 4 .636 
Likelihood Ratio 2.770 4 .597 
N of Valid Cases 112   
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
5.09. 
 
 Though <1 year mortality is 40% which is  slightly higher when compare 
to other age groups. There is no statistical significance between age group and 
mortality. 
 
  
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Upto 6 Months > 6 - 1 yr > 1 - 5 yrs 6 - 10 yrs > 10 yrs
Age with Mortality
Non Survivor Survivor
 53   
 
 
GENDER WITH MORTALITY 
 
 Non Survivor Survivor 
Female 31.5% 68.5% 
Male 36.2% 63.8% 
 
Gender * Mortality Crosstabulation 
 
Mortality 
Total 
Non 
Survivor Survivor 
Gender 
Female 
Count 17 37 54 
% within 
Gender 31.5% 68.5% 100.0% 
Male 
Count 21 37 58 
% within 
Gender 36.2% 63.8% 100.0% 
Total 
Count 38 74 112 
% within 
Gender 33.9% 66.1% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square .279a 1 .598   
Continuity 
Correctionb .108 1 .743   
Likelihood Ratio .279 1 .597   
Fisher's Exact 
Test    .691 .372 
N of Valid Cases 112     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
18.32. 
b. Computed only for a 2x2 table 
 
 
 Male non survivor = 36.2%, Female non survivor = 31.5%. Though there is 
increased percentage preponderance for male sex, there is no statistical 
significance between sex and mortality. 
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SECONDARY OUTCOME  
 
NEED FOR VENTILATION 
 Normal Positive 
No 50.6% 6.1% 
Yes 49.4% 93.9% 
 
 
Groups 
Total 
Normal Positive 
V 
No 
Count 40 2 42 
% within 
Groups 50.6% 6.1% 37.5% 
Yes 
Count 39 31 70 
% within 
Groups 49.4% 93.9% 62.5% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 19.731a 1 .000   
Continuity 
Correctionb 17.875 1 .000   
Likelihood Ratio 23.596 1 .000   
Fisher's Exact 
Test    .0005 .000 
N of Valid Cases 112     
a. 0 cells (.0%) have expected count less than 5.  
The minimum expected count is 12.38. 
b. Computed only for a 2x2 table 
 
 There was a significant statistic correlation p value = 0.0005 between 
cardiac dysfunction and need for ventilation. 
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NEED FOR IONOTROPIC SUPPORT 
 
 Normal Positive 
No 43.0% 3.0% 
Yes 57.0% 97.0% 
 
 
Groups 
Total 
Normal Positive 
IS 
No 
Count 34 1 35 
% within 
Groups 43.0% 3.0% 31.3% 
Yes 
Count 45 32 77 
% within 
Groups 57.0% 97.0% 68.8% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact 
Sig. (1-
sided) 
Pearson Chi-
Square 17.342a 1 .000   
Continuity 
Correction 15.529 1 .000   
Likelihood Ratio 22.180 1 .000   
Fisher's Exact 
Test    .0005 .000 
Linear-by-
Linear 
Association 
17.187 1 .000   
N of Valid Cases 112     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
10.31. 
b. Computed only for a 2x2 table 
 
 There was a significant statistic correlation p value = 0.0005 between 
cardiac dysfunction and need for Ionotropic Support. 
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NEED FOR HIGHER NUMBER OF IONOTROPES 
 Normal Positive 
None 43.0% 6.1% 
1 43.0% 36.4% 
2 13.9% 45.5% 
>2 0.0% 12.1% 
 
 
Groups 
Total 
Normal Positive 
No of IS 
None 
Count 34 2 36 
% within 
Groups 43.0% 6.1% 32.1% 
1 
Count 34 12 46 
% within 
Groups 43.0% 36.4% 41.1% 
2 
Count 11 15 26 
% within 
Groups 13.9% 45.5% 23.2% 
> 2 
Count 0 4 4 
% within 
Groups 0.0% 12.1% 3.6% 
Total 
Count 79 33 112 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. Sig.  
(2-sided) 
Pearson Chi-Square 29.698a 3 .0005 
Likelihood Ratio 32.123 3 .000 
Linear-by-Linear 
Association 28.509 1 .000 
N of Valid Cases 112   
a. 2 cells (25.0%) have expected count less than 5. The minimum expected count 
is 1.18. 
 
 This diagram depicts the need for >1 number of ionotropes there is a 
statistical significance of p value  0.0005 between cardiac dysfunction and >1 
ionotropic support. 
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SHOCK CORRECTED AND REFRACTORY SHOCK 
 
 Normal Positive 
No 34.7% 39.4% 
Yes 65.3% 60.6% 
 
 
 
Groups 
Total 
Normal Positive 
SC 
NO 
Count 17 13 30 
% within 
Groups 34.7% 39.4% 36.6% 
YES 
Count 32 20 52 
% within 
Groups 65.3% 60.6% 63.4% 
Total 
Count 49 33 82 
% within 
Groups 100.0% 100.0% 100.0% 
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Chi-Square Tests 
 Value df 
Asymp. 
Sig. (2-
sided) 
Exact 
Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-
Square .188a 1 .665   
Continuity 
Correctionb .040 1 .842   
Likelihood Ratio .187 1 .665   
Fisher's Exact 
Test    .815 .419 
N of Valid Cases 82     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
12.07. 
b. Computed only for a 2x2 table 
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DURATION OF HOSPITAL STAY WITH OUTCOME 
 
Group Statistics 
Groups N Mean Std. Deviation Std. Error Mean 
Duration 
Normal 79 6.75 7.680 .864 
Positive 33 9.82 11.190 1.948 
 
 
Independent Samples Test 
 
t-test for Equality of Means 
t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
Duration -1.441 45.116 .156 -3.071 2.131 
 
 
 
 
  
 69   
 
 
 
 
 
 
This graph depicts the median days of hospital stay in each group. 
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DISCUSSION 
 
 Cardio vascular dysfunction and myocardial necrosis is one of the 
commonest complications encountered by children admitted in PICU. Acute 
Severe Myocardial Dysfunction Contributes A Significant Cause Of 
Mortality And Morbidity In Critically Ill Children Admitted In PICU. 
Severity assessment of illness and outcome in critically ill children is 
important as it influences management strategies and resource allocation. 
Myocardial ischemia, myocyte death may occur directly due to stress factors 
imposed on heart due to several  Non cardiac etiology such as Hypoxia, 
shock, sepsis, Acute kidney injury, MODS, electrolyte abnormalities, 
hypovolemia, anemia, hypertension, post surgery, drugs, toxins released due 
to viral and other underlying infections. Second phase there is direct 
myocyte death due to direct effects and also activation of innate immune 
response which contributes to further myocardial damage. Third phase the 
antibodies released by viral specific responses continue to damage 
myocardium resulting in dilated cardiomyopathy in a genetically 
predisposed individual. Myocardial damage results in contractile 
dysfunction and ventricular dilatation. Papillary muscle dysfunction can 
cause valvular regurgitation. Pericardial effusion can also occur. 
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 This study was performed to determine cardiovascular changes with 
various diagnostic modalities in early diagnosis of myocardial injury and 
early intervention thereby facilitating better treatment protocol and thereby 
subsequent reduction in mortality & morbidity. In this study we studied 
cardiac status of critically ill children with parameters like elevated 
Troponin T, Bedside ECHO changes like fall in ejection fraction, valvular 
regurgitation, dilated cardiomyopathy, papillary muscle dysfunction, 
pulmonary hypertension and ECG changes like T Wave Inversion, ST 
Elevation, U Wave, Q Wave abnormality. 
 
 BASHEIR ET AL study showed there was a statistically significant 
positive correlation between mortality and high troponin t levels. 
 
 FENTON ET AL study studied the increase in serum levels of 
troponin I associated with cardiac dysfunction and disease severity in 
pediatric patients with septic shock. 
 
 SJ CLARK ET AL studied the role of troponin t in critically ill 
children in PICU without congenital heart disease. They found a positive 
correlation between high troponin t and PIM score and concluded that 
neonates have higher troponin t levels compared to infants despite having 
less severe disease. 
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 AMMANN ET AL study analysed critically ill patients according to 
their troponin status.higher troponin levels were associated with higher 
mortality and lower LVEF. Troponin positive patients have significantly 
higher median levels of tumour necrosis factor alpha and interleukin 6. 
 
 C SPIES ET AL study objective was to investigate troponin t as early 
marker of myocardial injury and a prognostic marker of early sepsis. In our 
study there was  a statistically significant association between elevated 
TROPONIN T values and cardiac dysfunction. Children with Respiratory 
diseases, viral myocarditis, septic shock, Acute CNS infection, had 
statistically significant cardiac dysfunction when compared to other 
illnesses.  
 
 Regarding positive troponin t levels and echocardiographic changes 
children with significant structural changes in echocardiogram were positive 
for Troponin-T. 
 
 33 children out of 112 children had cardiac dysfunction evident with 
elevated Troponin-T levels. Total mortality was 38 children out of which 25 
children had elevated troponin t levels. Echocardiographic abnormality was 
found among 13 children all 13 had elevated troponin t levels. 33 children in 
the study had positive ECG findings and among those children 14 children 
had elevated troponin t levels  
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 36 children with Respiratory diseases like bronchopneumonia, 
aspiration pneumonia, pyothorax, near fatal asthma, bronchiolitis, WALRI, 
collapse with consolidation were studied. 12 children had cardiac 
dysfunction. 30% of children had cardiac dysfunction  
 
 Viral myocarditis cases 3 cases were studied. All children had 
significant cardiac dysfunction, with positive Troponin-T levels, positive 
ECHO like fall in LVEF, Dilated cardiomyopathy, Valvular regurgitation 
and ECG findings like ST elevation, T wave inversion 100% cardiac 
dysfunction observed in such children. Our study correlates well with 
AMMANN ET AL. 
 
 29 children with CENTRAL NERVOUS SYSTEM illnesses like 
Acute CNS infections, encephalitis, GBS, hydrocephalus, Status epilepticus, 
refractory seizures, intracranial hemorrhage, demyelinating illnesses were 
studied.40% of acute CNS infection children had cardiac dysfunction,100% 
of encephalitis children had cardiac dysfunction. Total of 5 children out of 
29, 17.5 % had cardiac dysfunction 
 
 9 children with GIT disorders were included in the study, 2 had 
cardiac dysfunction, 22.2% of these children had cardiac dysfunction. 
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 Children with septic shock all had cardiac dysfunction making 
association of 100%which indicates sepsis causes early myocyte damage 
and necrosis.in this aspect our study correlates with C SPIES ET AL & 
FENTON ET AL. 
 
 Scorpion sting cases  50% had cardiac dysfunction, IEM children 
66.7% of them  had cardiac dysfunction 
 
 Diabetic keto acidosis children had no cardiac dysfunction whereas 
congenital hypothyroidism with pericardial effusion had cardiac dysfunction 
with elevated Troponin-T, Positive ECHO and ECG findings. 
 
 Acute kidney injury case on hemodialysis had no cardiac dysfunction 
Children with viral fever with thrombocytopenia had no underlying cardiac 
dysfunction. 
 
 Various poisonings and snake bite cases also had no underlying 
cardiac dysfunction. 
 
 In our study 33 out of 112 children - 29.5% had clinical evidence of 
myocardial injury testing positive for Troponin T.  
 
 13 cases tested positive for all 3 modalities ECHO, ECG &  
Troponin-T. Total mortality was 38 children among which 25 had elevated 
Troponin-T levels. 
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 In our study we found that there was a statistically significant 
correlation with positive Troponin T levels in terms of mortality and 
morbidity in form of need for ventilation, shock correction, ionotropic 
support, duration of hospital stay and prompt early detection of myocyte 
damage can improve the outcome with appropriate intervention. Cardiac 
troponin t has been used to assess the prevalence of myocardial injury in 
critically ill children in PICU supported  by ECHO,ECG findings. Our study 
coin cides with the one observed by SJ CLARK ET AL 
 
 Overall Troponin T is a valuable tool for early detection of myocyte 
damage and assessment of cardiac status in critically ill children in PICU. 
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COMPARISON WITH OTHER STUDIES 
Parameter Our study Clark et al 
Bashir 
Hassan et al 
KE 
fenton et al 
King et al 
Sample 
PICU 
112 cases 
PICU 
47cases 
60controls 
PICU 
25cases 
25controls 
PICU 
23 septic 
shock cases 
ICU 120 cases 
ECG changes 33 cases     
ECHO 
changes 
13 cases  
Present in 22 
cases 
13 cases  
LVEF 
shortening 
12 cases  
Shortening in 
22 cases 
LVEF fall in 
13 cases 
 
Troponin 
High in 33 
cases 
High in 17/22 
ventilated 
infants 
High in 
22cases 
correlates 
with 
ventricular 
dysfunction 
Troponin I 
increased in 
13 cases 
Troponin I 
elevated in 15 
cases of sepsis 
Mortality 38 2 cases 16 cases 10 24 
Remarks 
Positive 
correlation 
between 
positive cTnT 
and mortality 
& morbidity 
Negative 
correlation 
with LVEF 
Positive 
correlation 
between 
cTNT and 
mortality 
score 
Positive 
correlation 
between 
cTNT and 
PIM II score, 
mortality, 
severity. 
Negative 
correlation 
with LVEF 
Troponin I 
increase in 
>50% of 
septic 
children 
Correlated 
with PIM II 
mortality 
score and 
multiple 
organ failure 
TROPONIN 
increase 
correlated with 
APACHE II 
score, positive 
correlation in 
multiorgan 
dysfunction 
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Parameter Our study Agrawal et al Costa et al 
Thiru y 
et al 
Sample 
PICU 
112 cases 
NICU 
60 asphyxiated 
NICU 
29asphyxiated 
30 controls 
PICU 101 cases 
meningococcal 
septicemia 
ECG changes 33 cases 
Present in 46 
infants 
Present  
ECHO 
changes 
13 cases  Present 32 cases 
Ejection 
fraction 
12 cases  Present in 1 
LVEF shortening 
in 32 cases 
Troponin 
High in 33 
cases 
CK,CK-MB, 
Troponin 
elevated 
LVEF shortening 
in asphyxiated 
Troponin T high 
in 63 cases 
Mortality 38 16 9  
Remarks 
Positive 
correlation 
between 
positive cTnT 
and mortality 
& morbidity 
Negative 
correlation 
with LVEF 
Troponin I 
&CK-MB 
were elevated 
in asphyxiated 
and in non-
survivors 
Troponin T 
valuable tool in 
asphyxiated 
babies to detect 
myocardial injury 
Positive 
correlation with 
Troponin levels, 
diseases severity, 
myocardial 
depression and 
ionotropic support 
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LIMITATIONS OF THE STUDY 
 
1. There was no control group in the study. 
2. No serial Troponin-T levels & Serial Echocardiogram, Serial ECG 
was done. 
3. Comparison with other cardiac bio-markers like CK-MB, LDH, 
Troponin-I was not done. 
4. Autopsy was not done in non-survivors as parents refused to give 
consent. 
  
Recommendations 
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RECOMMENDATIONS 
 
1. Cardiac dysfunction is not limited to cardiovascular system alone 
hence children with other non cardiac etiology illnesses have to be 
evaluated for cardio vascular dysfunction. 
 
2. Cardiac abnormalities in PICU are often under diagnosed and hence 
high index of suspicion and investigation for the same are required. 
 
3. Troponin–T, ECG and ECHO help in early recognition and hence 
better management of critically ill children in PICU. 
  
Conclusion 
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CONCLUSION 
 
 Myocardial assessment was done in critically ill children in picu 
revealed  myocardial damage occuring in non-cardiac illnesses. 29.5% 
among the  total children had cardiac dysfunction. Cardiac dysfunction was 
evident by the gold standard quantitative ECLIA positive Troponin T levels 
cardiac dysfunction was supported by Bedside ECHO, ECG findings. There 
was increased incidence of overall mortality in children with cardiac 
dysfunction. Children with cardiac dysfunction also needed prolonged 
ventilatory support, ionotropic support and shock correction. Duration of 
hospital stay was also high in children with cardiac dysfunction. Troponin 
T, ECHO, ECG findings were significantly positive among non-survivors. 
 
 Low Ejection fraction, Dilated cardiomyopathy, Papillary muscle 
dydfunction, Valvular regurgitation ,pulmonary hypertension were present 
in children with cardiac dysfunction. T Wave changes, ST changes, low 
voltage complexes, U wave, Tachycardia were significant ECG findings. 
Further studies are necessary to validate these findings. 
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Annexures 
ABBREVIATIONS 
 
1. cTnT  - TROPONIN T 
2. cTnI  - TROPONIN I 
3. ECG  - ELECTROCARDIOGRAM 
4. ECHO - ECHOCARDIOGRAM 
5. CXR  - CHEST XRAY 
6. LVEF  - LEFT VENTRICULAR EJECTION FRACTION 
7. PICU  - PEDIATRIC INTENSIVE CARE UNIT 
8. NICU  - NEONATAL INTENSIVE CARE UNIT 
9. CK-MB - CREATININE KINASE MYOCARDIAL BOUND 
10. LDH  - LACTATE DEHYDROGENASE 
11. CVS  - CARDIOVASCULAR SYSTEM 
12. RS  - RESPIRATORY SYSTEM 
13. GIT  - GASTROINTESTINAL SYSTEM 
14. CNS  - CENTRAL NERVOUS SYSTEM 
15. IEM  - INBORN ERRORS OF METABOLISM 
16. PIM-II SCORE - PEDIATRIC INDEX OF MORTALITY SCORE 
17. MOD  - MULTI ORGAN DYSFUNCTION  
  
  
 
  
 
  
 
  
INFORMATION SHEET FOR THOSE WHO PLAN TO 
PARTICIPATE IN THE RESEARCH PROJECT 
 
NAME OF THE RESEARCH PROJECT 
ASSESSMENT OF MYOCARDIAL STATUS IN CRITICALLY ILL CHILDREN 
ADMITTED IN PICU- A PROSPECTIVE OBSERVATIONAL STUDY 
 
We welcome you and thank you for having accepted our request to consider 
whether your child can participate in our study. This sheet contains the details of 
the study; the possible risks, discomfort and benefits for the participants are also 
given. 
 
You can read and understand by yourself; if you wish we are ready to read and 
explain the same to you. 
 
If you do not understand on the details of  study or if you wish for further details 
we are ready to provide the details. 
 
Information to the participants 
 
What is the purpose of the study? 
To assess the myocardial status in critically ill children admitted in PICU of 
Stanley medical college 
 
Who/where is the study is being conducted? 
PICU, Institute of Social Paediatrics, Stanley Medical College 
 
Why our child is being considered as one of the participant? 
Your child has been considered as the participant as he/she is the person who is 
fulfilling the criteria of inclusion&exclusion 
 
Should our child definitely has to take part in the study? 
No.if you do not wish your child to participate,your child will not be included in 
the study.in addition your child will continue to get the medical treatment without 
any prejudice. 
 
If my child is participating in the study,what are my responsibilities? 
Your responsibilities are 
1.to allow us perform blood investigations(2 ml of blood will be drawn) 
2.to co-operate while performing the test 
3.to answer reliably when asked for 
4.to inform if your child has any discomfort during the study period 
 
  
Are there any benefits for our child/public? 
Yes 
 
Will there be any discomfort/risks to my child? 
There is  no risk or discomfort involved in the study 
 
Will I be paid for the study? 
No.you will not be paid. 
 
Will our child’s participation in this study,our child’s personal details will be 
kept confidentially? 
Yes,confidentiality will be maintained 
 
Will I be informed of this study’s results and findings? 
Yes,if you want you  can get the details from us. 
 
Can I withdraw my child from this study at any time during the study 
period? 
Yes, you can withdraw your child at any time during the study period. 
  
 
  
/ daughter, by 
 
  
  
  
 
  
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
VENTI 
LATION
SHOCK 
CORRECTED/N
OT
DURATION 
OF PICU 
STAY
TREATMENT- 
MEDICAL / 
SURGICAL
SERUM 
TROPONIN 
T(ECLIA)
RESULTS
ECHO 
CARDIOGRAM
12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
1 B/O SABITHA 1 MONTH MCH COUGH,BREATHLESSNESS BRONCHOPNEUMONIA
BRONCHOPNEUMONIA,CULT
URE POSITIVE 
SEPSIS,CIRCULATORY SHOCK
YES YES1 NO YES 17 DAYS MEDICAL 0.08 NORMAL
NORMAL 
STUDY
TACHYCARDIA ABNORMAL SURVIVOR
2 ABBAS 5 MONTHS MCH COUGH,BREATHLESSNESS BRONCHOPNEUMONIA
BRONCHOPNEUMONIA,CULT
URE POSITIVE 
SEPSIS,CIRCULATORY SHOCK
YES YES1,2,3 YES NO 13 DAYS MEDICAL 0.8 POSITIVE
NORMAL 
STUDY
TACHYCARDIA ABNORMAL NON-SURVIVOR
3 JOHN DHAYA 4 MONTHS MCH
LETHARGY,CONSTIPATION
,SUDDEN 
UNRESPONSIVENESS
CONGENITAL 
HYPOTHYROIDISM
CONGENITAL 
HYPOTHYROIDISM,THYROID 
DYSGENESIS
NO NO NO NO 15 DAYS MEDICAL 0.13 POSITIVE
PERICARDIAL 
EFFUSION WITH 
PULMONARY 
STENOSIS
LOWVOLTAGE 
COMPLEXES
ABNORMAL SURVIVOR
4 DHARSHINI 9 MONTHS FCH COUGH BREATHLESSNESS BRONCHOPNEUMONIA PYOTHORAX YES YES 1 YES YES 34 DAYS MEDICAL/ICD 0.45 POSITIVE
LVEF 
DECREASED
TACHYCARDIA,
T WAVE 
DEPRESSION
ABNORMAL NON-SURVIVIOR
5 DINESH 10 YEARS MCH
CONTACT WITH 
ELECTRICAL SOURCE 
,CONVULSIONS
ELECTROCUTION WITH 
STATUS EPILEPTICUS
ELECTROCUTION WITH 
STATUS 
EPILEPTICUS,ASPIRATION 
PNEUMONITIS
NIL YES 1 YES YES 7 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
TACHYCARDIA  ABNORMAL SURVIVOR
6 ANUSHKA 8 YEARS FCH SCORPON STING
SCORPION 
ENVENOMATION
SCORPION ENVENOMATION 
WITH CARDIOGENIC SHOCK
YES YES2 YES YES 4 DAYS MEDICAL 0.631 POSITIVE
LVEF 
DECREASED
TACHYCARDIA NORMAL SURVIVOR
7 KANGAIYAN 4 MONTHS MCH CONVULSIONS ACUTE CNS INFECTION ACUTE CNS INFECTION YES YES1 NO YES 3 DAYS MEDICAL 0.02 NORMAL
NORMAL 
STUDY
TACHCARDIA NORMAL SURVIVOR
8 SELVA 18 MONTHS MCH BREATHLESSNESS NEAR FATAL ASTHMA NEAR FATAL ASTHMA NO YES YES YES 9 DAYS MEDICAL 0.011 NORMAL
NORMAL 
STUDY
WNL
HYPERINFLA
TION
SURVIVOR
9 MOUVANTHIKA 3MONTHS FCH
BREATHLESSNESS,REFUSA
L OF FEEDS
LOS/BRONCHOPNEUMO
NIA
LATE ONSET SEPSIS/SEPTIC 
SHOCK/BRONCHOPNEUMON
IA
YES YES4 YES YES 9 DAYS MEDICAL 0.15 POSITIVE
NORMAL 
STUDY
TACHYCARDIA ABNORMAL SURVIVOR
10 POOJA
2 YEARS 6 
MONTHS
FCH FEVER,BREATHLESSNESS
GLOBAL 
DEVELOPMENTAL 
DELAY/SEIZURE 
DISORDER/ASPIRATION 
PNEUMONITIS 
GDD/ASPIRATION 
PNEUMONIA/SEIZURE 
DISORDER/CULTURE 
POSITIVE SEPSIS
YES YES1 YES YES 2 MONTHS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
WNL ABNORMAL SURVIVOR
11 SABARISHWARAN 2 MONTHS MCH
BREATHLESSNESS,REFUSA
L OF FEEDS
CLEFT LIP/CLEFT 
PALATE/LOS/DUODENAL 
PERFORATION
CLEFT LIP/CLEFT 
PALATE/DUODENAL 
PERFORATION/LOS/PERSISTE
NT HYPOGLYCEMIA
YES YES1 YES YES 15 DAYS
MEDICAL/SU
RGICAL
0.22 POSITIVE
NORMAL 
STUDY
TACHYCARDIA NORMAL NONSURVIVOR
12 GOWTHAM 2 MONTHS MCH BREATHLESSNESS BRONCHOPNEUMONIA
RIGHT U/L COLLAPSE WITH 
CONSOLIDATION
YES YES3 YES YES 15 DAYS MEDICAL 0.05 NORMAL
NORMAL 
STUDY
WNL ABNORMAL SURVIVOR
13 GOPINATH 2 YEARS MCH
ALTERED 
SENSORIUM,CONVULSION
S
ACUTE CNS INFECTION 
/STATUS EPILEPTICUS
ACUTE CNS 
INFECTION/STATUS 
EPILEPTICUS
YES YES1,3 YES YES 4 DAYS MEDICAL 0.25 POSITIVE
LVEF 
DECREASED
TACHYCARDIA ABNORMAL NONSURVIVOR
14 JEEVITHA 4 MONTHS FCH
COUGH,BREATHLESSNESS,
FEVER
BRONCHOPNEUMONIA
BRONCHOPNEUMONIA/FTT/
DIVC/SEPTIC SHOCK
YES YES1,3,4 YES NO 3 DAYS MEDICAL 0.36 POSITIVE
LVEF 
DECREASED
TACHYCARDIA,
T WAVE 
DEPRESSION
ABNORMAL NONSURVIVOR
15 SIVAGAMI
6 YEARS 
6MONTHS
FCH BREATHLESSNESS,FEVER
GDD/SPASTIC 
CP/SEIZURE 
DISORDER/ASPIRATION 
PNEUMONIA
GDD/SPASTIC CP/SEIZURE 
DISORDER/ASPIRATION 
PNEUMONIA
YES YES1,3 YES YES 2 DAYS MEDICAL 0.O7 NORMAL
NORMAL 
STUDY
TACHYCARDIA ABNORMAL NONSURVIVOR
16 SUGANYA 4 MONTHS FCH BREATHLESSNESS,FEVER BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES1 YES YES 12 DAYS MEDICAL 0.04 NORMAL
NORMAL 
STUDY
WNL ABNORMAL SURVIVOR
17 SARAN 3 YEARS MCH FEVER,BREATHLESSNESS SEPSIS WITH SHOCK
RIGHT EMPYEMA,SEVERE 
SEPSIS,SEPTIC 
SHOCK,MODS,RESPIRATORY 
FAILURE
YES YES1,2,3 YES NO  1 DAY MEDICAL 0.52 POSITIVE
LVEF 
DECREASED
TACHYCARDIA ABNORMAL NON-SURVIVOR
18 SANTHOSH 11 YEARS MCH
HANGING,ALTEREDSENSO
RIUM
HANGING HANGING YES YES1 YES YES 6 DAYS MEDICAL 0.07 NORMAL
NORMAL 
STUDY
TACHYCARDIA ABNORMAL SURVIVOR
MASTER CHART
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
VENTI 
LATION
SHOCK 
CORRECTED/N
OT
DURATION 
OF PICU 
STAY
TREATMENT- 
MEDICAL / 
SURGICAL
SERUM 
TROPONIN 
T(ECLIA)
RESULTS
ECHO 
CARDIOGRAM
12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
19 SARANYA 10 YEARS FCH
ALTERED 
SENSORIUM,CONVULSION
S
SEIZURE 
DISORDER,PACHYGYRIA,
ASPIRATION 
PNEUMONITIS
SEIZURE 
DISORER,PACHYGYRIA,ASPIR
ATION PNEUMONITIS
YES YES1,3 YES YES 27 DAYS MEDICAL 0.064 NORMAL
NORMAL 
STUDY
TACHYCARDIA ABNORMAL SURVIVOR
20 SAKTHI 9 YEARS FCH ALTERED SENSORIUM
ACUTE 
ENCEPHALITIS,STATUS 
EPILEPTICUS,MODS/DIV
C/REFRACTORY SHOCK
ACUTE 
ENCEPHALITIS/STATUS 
EPILEPTICUS/MODS/DIVC/RE
FRACTORY SHOCK
YES YES1,2,3 YES NO 3 DAYS MEDICAL 0.35 POSITIVE
NORMAL 
STUDY
TACHYCARDIA ABNORMAL NONSURVIVOR
21 SANJAY 12 YEARS MCH BREATHLESSNESS STATUS ASTHMATICUS
STATUS ASTHMATICUS/NEAR 
FATAL ASTHMA
NO YES1 YES NA 6 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
WNL
HYPERINFLA
TION
SURVIVOR
22 AMSA 5 MONTHS FCH NON SURVIVOR
IEM/UREA CYCLE 
DISORDER/STATUS 
EPILEPTICUS/SEPSIS
IEM/UREA CYCLE 
DISORDER/STATUS 
EPILEPTICUS/SEPSIS
YES YES1,3 YES NO 2 DAYS MEDICAL 0.7 POSITIVE
LVEF 
DECREASED
TACHYCARDIA NORMAL NONSURVIVOR
23 LASHYA 4 MONTHS FCH
BREATHLESSNESS/ABNOR
MAL BREATHING SOUND
BRONCHOPNEUMONIA,L
ARYNGOMALACIA
BRONCHOPNEUMONIA,LARY
NGOMALACIA
NO NO YES NA 6 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
WNL
BRONCHOP
NEUMONIA
SURVIVOR
24 PUGALINIYAN
2 YEARS 6 
MONTHS
MCH
BREATHLESSNESS,FEVER,R
EFUSAL OF FEEDS
BRONCHOPNEUMONIA 
,SEPTIC SHOCK
BRONCHOPNEUMONIA,SEPTI
C SHOCK
YES YES1,3 YES YES 17 DAYS MEDICAL 0.32 POSITIVE
NORMAL 
STUDY
WNL
BRONCHOP
NEUMONIA
SURVIVOR
25 KAVIN 1 YEAR MCH COUGH,FEVER BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES 1 NO YES 8 DAYS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
WNL
BRONCHOP
NEUMONIA
SURVIVOR
26 ROHITH 36 DAYS MCH LOOSESTOOLS,LETHARGY
ADD SEVERE 
DEHYDRATION,
 ADD SEVERE 
DEHYDRATION,SEPTIC 
CARDIOGENIC SHOCK
YES YES1,3 YES NO 2 HRS MEDICAL 0.44 POSITIVE
LVEF 
DECREASED
TACHYCARDIA NORMAL NONSURVIVOR
27 RAHINI 36 DAYS FCH
LOOSESTOOLS,VOMITING,
FAILURE TO GAIN WEIGHT
ADD SEVERE 
DEHYDRATION,FTT
ADD SEVERE 
DEHYDRATION,FTT
YES NO NO NO 5 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
28 SAIMITHRAN
2 YEARS 6 
MONTHS
MCH LETHARGY,CONVULSIONS ACUTE CNS INFECTION DEMYELINATING DISEASE YES YES 1,3 YES NO 16 DAYS MEDICAL 0.008 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NON-SURVIVOR
29 KISHORE 2 YEARS MCH
SALICYLATE 
CONSUMPTION
SALICYLATE POISONING SALICYLATE POISONING NO NO NO NA 2 DAYS MEDICAL 0.006 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
30 VIJAYSHREE 1 MONTH FCH
VOMITING,ABDOMINAL 
DISTENSION
LOS LOS NO NO NO NA 2 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
31 KAVYA 2 YEARS FCH BREATHLESSNESS WALRI WALRI NO NO NO NA 2 DAYS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
NORMAL
HYPERINFLA
TION
SURVIVOR
32 PIYUSH KUMAR 10 YEARS MCH OPC CONSUMPTION OPC POISONING OPC POISONING NO NO NO NA 2 DAYS MEDICAL 0.008 NORMAL
NORMAL 
STUDY
TACHYCARDIA NORMAL SURVIVOR
33 SUDHASRI 7 YEARS FCH SEIZURES MYOCLONIC SEIZURES MYOCLONIC SEIZURES NO NO NO NA 4 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
34 KAJAL KUMARI 4 YEARS FCH LOOSE STOOLS
ADD SEVERE 
DEHYDRATION
ADD SEVERE DEHYDRATION YES NO NO NA 3 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
35 SANJANA  9 YEARS FCH FEVER
FEVER WITH 
THROMBOCYTOPENIA
HLH YES YES1 NO NA 9 DAYS MEDICAL 0.008 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
36 RIDHU VARSHINI
1 YEAR 6 
MONTHSFCH
KEROSENE INGESTION KEROSENE INGESTION KEROSENE INGESTION NO NO NO NA 2 DAYS MEDICAL 0.006 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
37 LIKESH
1 YEAR 6 
MONTHSFCH
MCH BREATHLESSNESS
BRONCHOPNEUMONIA 
SEPTIC SHOCK
BRONCHOPNEMONIA SEPTIC 
SHOCK
YES YES 4 YES YES 5 DAYS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
38 RITHIKA SRI 4 YEARS FCH LOOSESTOOLS
ADD SEVERE 
DEHYDRATION FTT
ADD SEVERE DEHYDRATION 
FTT
YES NO NO NA 6 DAYS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
39 VISHWA 8 YEARS MCH
NEAR DROWNING 
RESPIRATORY DISTRESS
NEAR DROWNING 
FRESH WATER NEAR 
DROWNING
NO NO NO NA 4 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
TACHYCARDIA ABNORMAL SURVIVOR
40 SAMPOORNAM 29 DAYS FCH
VOMITING,ABDOMINAL 
DISTENSION
LOS LOS,SEPTIC ILEUS YES NO NO NA 7 DAYS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
WNL NORMAL SURVIVOR
41 KARTHI 7 YEARS MCH
ALTERED 
SENSORIUM,SEIZURES
ACUTE CNS INFECTION
SUPER REFRACTORY 
SEIZURES,ACUTE CNS 
INFECTION
YES  YES1 YES YES
1 MONTH 5 
DAYS
MEDICAL 0.4 POSITIVE
NORMAL 
STUDY
TACHYCARDIA VAP NONSURVIVOR
42 KALPANA 3 YEARS FCH
FEVER,ALTERED 
SENSORIUM
ACUTE CNS INFECTION ACUTE CNS INFECTION YES YES1 NO YES 5 DAYS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
43 KARTHIK 10 YEARS MCH
BREATHLESSNESS,INCREA
SED URINE OUTPUT
DKA DKA YES NO NO NA 7 DAYS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
44 NAVEENKUMAR 12 YEARS MCH JAUNDICE WILSON'S DISEASE WILSON'S DISEASE NO NO NO NA 16 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
VENTI 
LATION
SHOCK 
CORRECTED/N
OT
DURATION 
OF PICU 
STAY
TREATMENT- 
MEDICAL / 
SURGICAL
SERUM 
TROPONIN 
T(ECLIA)
RESULTS
ECHO 
CARDIOGRAM
12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
45 DINESH KUMAR 6 YEARS MCH CONVULSIONS STATUS EPILEPTICUS
POST MENINGITIC 
SEQUELAE,STATUS 
EPILEPTICUS,GLOBAL 
DEVELOPMENTAL DELAY 
ASPIRATION PNEUMONITIS
YES YES 1,3 YES NO 2 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL
ASPIRATON 
PNEUMONIT
IS
NON SURVIVOR
46 CHARULATHA 10 MONTHS FCH
BREATHLESSNESS,COUGH,
COLD
BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES1,4 YES YES 9 DAYS MEDICAL 0.13 POSITIVE
LVEF 
DECREASED
T WAVE 
INVERSION
RIGHT 
UPPER LOBE 
COLLAPSE
NONSURVIVOR
47 NARESH 9 MONTHS MCH BREATHLESSNESS,FEVER BROCHOPNEUMONIA
BRONCHOPNEUMONIA,PNE
UMOTHORAX
YES YES 4 YES YES 6 DAYS MEDICAL 0.33 POSITIVE
NORMAL 
STUDY
NORMAL
PNEUMOTH
ORAX
NONSURVIVOR
48 B/O JAYALAKSHMI 1 MONTH MCH BREATHLESSNESS,FEVER
RIGHT UPPER LOBE 
COLLAPSE
RIGHT UPPER LOBE 
COLLAPSE
NO NO YES NA 5 DAYS MEDICAL 0.08 NORMAL
NORMAL 
STUDY
NORMAL
RIGHT 
UPPER LOBE 
COLLAPSE
SURVIVOR
49 SATYASEELAN 5 YEARS MCH BREATHLESSNESS,FEVER
MYOCARDITIS,CARDIOG
ENIC SHOCK
ACUTE 
MYOCARDITIS,REFRACTORY 
HYPOTENSIVE SHOCK
YES YES3 YES NO 1 DAY MEDICAL 0.45 POSITIVE LVEF 30%
T WAVE 
INVERSION
NORMAL NONSURVIVOR
50 CHARULATHA 11 YEARS FCH SNAKEBITE SNAKEBITE SNAKE BITE ENVENOMATION NO YES 1 YES YES 2 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
51 THASHWANTH 2 YEARS MCH BREATHLESSNESS,FEVER BRONCHOPNEUMONIA
SEVERE 
BRONCHOPNEUMONIA
NO YES 1 NA YES 7 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
52 SUDHANSRI 9 MONTHS MCH CONVULSIONS STATUS EPILEPTICUS MYOCLONIC SEIZURES NO YES 1 NA YES 8 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
53 ASHWIN
2 YEARS 6 
MONTHS
MCH BREATHLESSNESS BRONCHIOLITIS SEVERE BRONCHIOLITIS YES YES 1,3 NO YES 5 DAYS MEDICAL 0.9 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
54 B/O BHARATHY 2 MONTHS MCH BREATHLESSNESS BRONCHIOLITIS BRONCHIOLITIS NO YES 1 NA YES 5 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
55 GANGOTHRI 1 MONTH FCH BREATHLESSNESS,FEVER BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES 1 YES YES 7 DAYS MEDICAL 0.006 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
56 SABAREESH 10 YEARS MCH CONVULSIONS STATUS EPILEPTICUS
GLOBAL DEVELOPMENTAL 
DELAY/VP SHUNT 
FAILURE//CONGENITAL 
HYDROCEPHALUS
YES YES 1 YES YES 5 DAYS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
57 KAVESH 2 YEARS MCH CONVULSIONS ACUTE CNS INFECTION ACUTE CNS INFECTION NO YES 1 YES YES 4 DAYS MEDICAL 0.008 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
58 EZHUMALAI 11 YEARS MCH
COUGH,BREATHLESSNESS,
FEVER
BRONCHOPNEUMONIA
MR/MPS/HUNTER/BRONCH
OPNEUMONIA/PSEUDOMAN
AS POSITIVE SEPSIS
YES YES 1 YES YES 18 DAYS MEDICAL 0.32 POSITIVE
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
NONSURVIVOR
59 KIRAN KARTHIK 5 YEARS MCH RTA RIGHT THIGH INJURY
RIGHT THIGH 
DEGLOVING INJURY
RIGHT THIGH DEGLOVING 
INJURY
YES YES 1 YES YES 1 MONTH SURGICAL 0.72 POSITIVE
NORMAL 
STUDY
T WAVE 
INVERSION
NORMAL NONSURVIVOR
60 MADHAVAN
1 YEAR 4 
MONTHS
MCH CONVULSIONS
FEBRILE STATUS 
EPILETICUS/ASPIRATION 
PNEUMONIA
FEBRILE STATUS/ASPIRATION 
PNEUMONIA
YES YES 1,3 YES YES 4 DAYS MEDICAL 0.54 POSITIVE
NORMAL 
STUDY
NORMAL
ASPIRATON 
PNEUMONIT
IS
NONSURVIVOR
61 NASREEN BANU 3 MONTHS FCH BREATHLESSNESS BRONCHOPNEUMONIA
BRONCHOPNEUMONIA/SEPS
IS/RESPIRATORY 
FAILURE/DIVC
YES YES1,3 YES YES 1 DAY MEDICAL 0.87 POSITIVE
NORMAL 
STUDY
TACHYCARDIA,
T WAVE 
DEPRESSION
BRONCHOP
NEUMONIA
NONSURVIVOR
62 NIVETHA
1 YEAR 6 
MONTHS
FCH CONVULSIONS GDD/SEIZURE DISORDER
GDD/SEIZURE 
DISORDER/STATUS 
EPILEPTICUS
YES YES1,3 YES YES 1 DAY MEDICAL 0.009 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NONSURVIVOR
63 ISHWARYA 8 YEARS FCH BREATHLESSNESS
GDD/SPASTIC 
CP/SEIZURE 
DISORDER/ASPIRATION 
PNEUMONIA
GDD/SPASTIC CP/SEIZURE 
DISORDER/ASPIRATION 
PNEUMONIA
YES YES 1 YES YES 6 DAYS MEDICAL 0.07 NORMAL
NORMAL 
STUDY
NORMAL
ASPIRATON 
PNEUMONIT
IS
NONSURVIVOR
64 BALAVINAYAGAM 3 YEARS MCH WEAKNESS OF ALL LIMBS GBS/AFP GBS/AFP NO NO YES YES 5 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
65 OVIYAN 7 YEARS MCH HEAD INJURY
SUBDURAL 
HEMORRHAGE/POST 
TRAUMATIC
SUBDURAL 
HAEMORHHAGE/POST 
TRAUMATIC
YES YES 1 YES YES 8 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
66 SANA TABASUM 2 YEARS FCH CONVULSIONS
DEVELOPMENTAL 
DELAY/SEIZURE 
DISORDER/WITHDRAWA
L SEIZURE
DEVELOPMENTAL 
DELAY/SEIZURE 
DISORDER/WITHDRAWAL 
SEIZURE
NO NO YES NA 1 DAY MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
VENTI 
LATION
SHOCK 
CORRECTED/N
OT
DURATION 
OF PICU 
STAY
TREATMENT- 
MEDICAL / 
SURGICAL
SERUM 
TROPONIN 
T(ECLIA)
RESULTS
ECHO 
CARDIOGRAM
12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
67 SANTHOSH 10 YEARS MCH CONVULSIONS
ACUTE CNS 
INFECTION/VIRAL 
ENCEPHALITIS/REFRACT
ORY HYPOTENSIVE 
SHOCK
ACUTE CNS INFECTION/VIRAL 
ENCEPHALITIS/REFRACTORY 
HYPOTENSIVE SHOCK
YES YES 1,3 YES NO 4 DAYS MEDICAL 0.024 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NONSURVIVOR
68 ANU 46 DAYS FCH BREATHLESSNESS/COUGH
LOS/ASPIRATION 
PNEUMONIA/REFRACTO
RY HYPOTENSIVE SHOCK
LOS/ASPIRATION 
PNEUMONIA/REFRACTORY 
HYPOTENSIVE SHOCK
YES YES1,3 YES NO 1 DAY MEDICAL 0.08 NORMAL
NORMAL 
STUDY
TACHYCARDIA,
ST ELEVATION
ASPIRATON 
PNEUMONIT
IS
NON SURVIVOR
69 MATHIVANI
3 YEARS 6 
MONTHS
FCH CONVULSIONS
ACUTE CNS 
INFECTION/BRONCHOPN
EUMONIA
ACUTE CNS 
INFECTION/BRONCHOPNEU
MONIA
YES YES 1 YES YES 2 DAYS MEDICAL 0.66 POSITIVE
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
70 B/O SUJA
2 YEARS 6 
MONTHS
FCH LOOSE STOOLS
FLOPPY INFANT/ADD 
WITH SEVERE 
DEHYDRATION/RENAL 
FAILURE/HYPOTHYROIDI
SM
FLOPPY INFANT/ADD WITH 
SEVERE 
DEHYDRATION/RENAL 
FAILURE/HYPOTHYROIDISM
YES YES 1 YES YES 7 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
71 MUSKAN FATHIMA 6 MONTHS FCH CONVULSIONS ACUTE CNS INFECTION ACUTE CNS INFECTION NO YES 1 YES NA 16 DAYS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
72 CHAARUMATHI 2 YEARS FCH CONVULSIONS
STURGEWEBER 
SYNDROME/DEVELOPM
ENTAL DELAY/SEIZURE 
DISORDER
STURGE WEBER 
SYNDROME/DEVELOPMENTA
L DELAY/SEIZURE DISORDER
NO NO YES NA 4 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
73 KANISHKA
2 YEARS 6 
MONTHSFCH
DROWSINESS ?DRUG 
POISONING
CARBAMAZEPINE 
POISONIG
CARBAMAZEPINE POISONING NO YES1 NO NA 2 DAYS MEDICAL 0.005 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
74 MOHANAPRIYA
2 YEARS 6 
MONTHS
FCH CONVULSIONS
DEVELOPMENTAL 
DELAY/STATUS 
EPILEPTICUS/BRONCHOP
NEUMONIA
DEVELOPMENTAL 
DELAY/STATUS 
EPILEPTICUS/BRONCHOPNEU
MONIA
NO YES 1 NO NA 4 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
75 B/O SANGEETHA 2 MONTHS FCH
BREATHLESSNESS/REFUSA
L OF FEEDS
LOS/BRONCHOPNEUMO
NIA/SUBGLOTTIC 
STENOSIS
LOS/BRONCHO 
PNEUMONIA/SUBGLOTTIC 
STENOSIS
NO YES 1 NO NA 2DAYS MEDICAL 0.09 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
76 NASREEN 9 MONTHS MCH FEVER/CONVULSIONS ACUTE CNS INFECTION ACUTE CNS INFECTION NO NO NO NA 3 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
77 CALAB 44 DAYS MCH BREATHLESSNESS
LOS/BROCHOPNEUMON
IA
LOS/BRONCHO PNEUMONIA NO YES 1 YES NA 6 DAYS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
78
SUBHASH 
CHANDRAN 
11 YEARS MCH
COUGH/FEVER/BREATHLE
SSNESS/SPASTIC 
CEREBRAL PALSY
SPASTIC 
CP/HYPOTENSIVE 
SHOCK/BRONCHOPNEU
MONIA
SPASTIC CP/HYPOTENSIVE 
SHOCK/BRONCHOPNEUMON
IA
YES YES 1,3 YES YES 8 DAYS MEDICAL 0.66 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
79 GOPINATH  2 YEARS MCH FEVER/CONVULSIONS
ACUTE CNS 
INFECTION/STATUS 
EPILEPTICUS/SHOCK
MENINGITIS/STATUS 
EPILEPTICUS/HYPOTENSIVE 
SHOCK
YES YES 1,3 YES YES 18 DAYS MEDICAL 0.54 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
80 HARIKASHREE 6 MONTHS FCH
UNRESPONSIVENESS/CON
VULSIONS
INTRACRANIAL 
HEMORRHAGE/LATE 
ONSET 
HDN/REFRACTORY 
SHOCK
ICH/LATE ONSET 
HDN/REFRACTORY SHOCK
YES YES 1,3 YES NO 6 HOURS MEDICAL 0.009 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
81 NIRMAL KUMAR 8 MONTHS MCH
VOMITING/REFUSAL OF 
FEEDS
?IEM/DEVELOPMENTAL 
DELAY
?INBORN ERROR OF 
METABOLISM/DEVELOPMEN
TAL DELAY/REFRACTORY 
SHOCK
YES YES 1,3 YES NO 1 HOUR MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
82 ANGELINE 3 MONTHS FCH FEVER/CONVULSIONS
ARNOLD 
CHIARI/HYDROCEPHALU
S/MENINGOMYELOCOEL
E/ACUTE CNS 
INFECTION/SEPTIC 
SHOCK
ARNOLD 
CHIARI/HYDROCEPHALUS/M
ENINGOMYELOCOELE/ACTE 
CNS INFECTION/SEPTIC 
SHOCK
YES YES 1,3 YES YES 4 DAYS MEDICAL 0.4 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
83 SARAN 3 YEARS MCH
FEVER/COUGH/HEMATE
MESIS
REFRACTORY SEPTIC 
SHOCK/MULTIORGAN 
FAILURE/RIGHT 
EMPYEMA
REFRACTORY SEPTIC 
SHOCK/MULTIORGAN 
FAILURE/RIGHT 
EMPYEMA/SEVERE SEPSIS
YES YES 1,4 YES NO 12 HOURS
MEDICAL,SU
RGICAL
0.52 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
84 AKASH 11 YEARS MCH ACCIDENTAL HANGING HANGING ACCIDENTAL HANGING NO YES 1 YES NA 5 DAYS MEDICAL 0.008 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
VENTI 
LATION
SHOCK 
CORRECTED/N
OT
DURATION 
OF PICU 
STAY
TREATMENT- 
MEDICAL / 
SURGICAL
SERUM 
TROPONIN 
T(ECLIA)
RESULTS
ECHO 
CARDIOGRAM
12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
85 HEMANTH 3 YEARS MCH FEVER/COUGH
BROCHOPNEUMONIA/G
LOBAL DEVELOPMENTAL 
DELAY/SEIZURE 
DISORDER
BRONCHOPNEUMONIA/GLO
BAL DEVELOPMENTAL 
DELAY/SEIZURE DISORDER
YES YES 1 YES YES 19 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
86 BHAVANA 1 YEAR FCH
LETHARGY/REFUSAL OF 
FEEDS
ACUTE CNS 
INFECTION/IEM-
TYROSINEMIA
ACUTE CNS INFECTION/IEM-
TYROSINEMIA
YES YES1,3 YES YES 4 DAYS MEDICAL 0.2 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
87 JEEVANANTHAM
1 YEAR 6 
MONTHSMC
H
COUGH/RESPIRATORY 
DISTRESS
BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES 1 YES YES 14 HOURS MEDICAL 0.003 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
NON SURVIVOR
88 DILANI 45 DAYS MCH BREATHLESSNESS
OESOPHAGEAL ATRESIA 
/GASTROSTOMY/ASPIRA
TION PNEUMONIA
OESOPHAGEAL 
ATERSIA/GASTROSTOMY/AS
PIRATION PNEUMONIA
YES YES 1,3 YES YES 5O DAYS MEDICAL 0.33 POSITIVE
NORMAL 
STUDY
NORMAL
RIGHT 
UPPER LOBE 
COLLAPSE
SURVIVOR
89 CHARMILA 7 YEARS FCH LETHARGY/POLYURIA DKA DKA NO NO NO NA 5 DAYS MEDICAL 0.007 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
90 FATHIMA 4 YEARS FCH
FEVER/HEMOPTYSIS/MAL
ENA
?ACUTE 
LEUKEMIA/SEPTIC 
SHOCK/SEPTICEMIA
?ACUTE LEUKEMIA/SEPTIC 
SHOCK/SEPTICEMIA
YES YES 1,4 YES NO 6 HOURS MEDICAL 0.12 POSITIVE
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
91 B/O PONNUMANI 58 DAYS MCH LOOSE STOOLS
FTT/ADD WITH SOME 
DEHYDRATION
FTT/ADD WITH SOME 
DEHYDRATION
YES NO NO NO 7 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
92 MONISH 1 YEAR MCH CONVULSIONS
ACCIDENTAL CAMPHOR 
INGESTION/ENCEPHALO
PATHY
ACCIDENTAL CAMPHOR 
INGESTION/CAMPHOR 
ENCEPHALOPATHY
NO NO NO NO 3 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
93 YUVARANI 6 YEARS FCH
VOMITING/LOOSE 
STOOLS
ACUTE KIDNEY INJURY ACUTE KIDNEY INJURY NO NO NO NO 7 DAYS MEDICAL 0.002 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
94 ANJALAI 10 YEARS FCH CONVULSIONS STATUS EPILEPTICUS STATUS EPILEPTICUS NO NO NO NO 4 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
95 GAYATHRI 3 YEARS FCH FEVER,BREATHLESSNESS
ACUTE 
MYOCARDITIS,CARDIOG
ENIC SHOCK
ACUTE 
MYOCARDITIS,REFRACTORY 
HYPOTENSIVE SHOCK
YES YES 3 YES NO 12 HOURS MEDICAL 0.7 POSITIVE LVEF 45% NORMAL
CARDIOMEG
ALY
NONSURVIVOR
96 CHRIST DENNIS 6 MONTHS MCH FEVER/BREATHLESSNESS BRONCHOPNEUMONIA BRONCHOPNEUMONIA NO NO NO NA 5 DAYS MEDICAL 0.002 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
97 TRISHIKA 44 DAYS FCH
PERINEAL 
GANGRENE/REFUSAL OF 
FEEDS
LOS/SEPTIC 
SHOCK/PERINEUM 
CELLULITIS/GANGRENE/
DIVC
LOS/SEPTIC 
SHOCK/PERINEAL 
CELLULITIS/GANGRENE/DIVC
YES YES1,4 YES NO 5 HOURS MEDICAL 0.35 POSITIVE LVEF 45%
TACHYCARDIA,
ST ELEVATION
DILATED 
BOWEL 
LOOPS
NON SURVIVOR
98 MAGILMATHI 1 YEAR FCH FEVER/BREATHLESSNESS BRONCHOPNEUMONIA BRONCHOPNEUMONIA YES YES 1 YES YES 7 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
99 MOHITH 10 MONTHS MCH FEVER/BREATHLESSNESS BRONCHOPNEUMONIA BRONCHIOPNEUMONIA YES YES 1 YES YES 8 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
100 SALMA 11 YEARS FCH FEVER
VIRAL FEVER WITH 
THROMBOCYTOPENIA
VIRAL FEVER WITH 
THROMBOCYTOPENIA
YES NO NO NO 2 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
101 ANITHA 8 YEARS FCH FEVER
VIRAL FEVER WITH 
THROMBOCYTOPENIA
VIRAL FEVER WITH 
THROMBOCYTOPENIA
YES NO NO NO 2 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
102 HARSHIKA 1 YEAR FCH FEVER,BREATHLESSNESS
WALRI/COMPENSATED 
SHOCK
WALRI/COMPENSATED 
SHOCK
YES YES 1 NO YES 2 DAYS MEDICAL 0.002 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
103 RUCHITRA 3 YEAR FCH SCORPON STING
SCORPION 
ENVENOMATION
SCORPION ENVENOMATION NO NO NO NO 2 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
104 RAMAN 4 MONTHS MCH FEVER,BREATHLESSNESS BRONCHIOLITIS BRONCHIOLITIS NO NO NO NO 3 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
105 ILAVARASAN 12 YEARS MCH FEVER
VIRAL FEVER WITH 
THROMBOCYTOPENIA
VIRAL FEVER WITH 
THROMBOCYTOPENIA
YES NO NO NO 4 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
106 MUTHUSELVAN 5 YEARS MCH ABDOMINAL PAIN/FEVER
APPENDICEAL 
PERFORATION/PYOPERI
TONITIS/ASPIRATION 
PNEUMONIA
APPENDICEAL 
PERFORATION/PYOPERITONI
TIS/ASPIRATION 
PNEUMONIA/LAPAROSCOPY 
DONE
YES YES1,3 YES YES 9 DAYS
SURGICAL/M
EDICAL
0.002 NORMAL
NORMAL 
STUDY
NORMAL
PNEUMOME
DIASTINUM
SURVIVOR
107 SUBHASH
3 YEARS 6 
MONTHS
MCH FEVER/BREATHLESSNESS
MYOCARDITIS,CARDIOG
ENIC 
SHOCK/CONGESTIVE 
CARDIAC 
FAILURE/SEVERE MR
MYOCARDITIS/CCF/CARDIOG
ENIC SHOCK/SEVERE MR
YES YES 3 YES NO 1 DAY MEDICAL 0.88 POSITIVE
DILATED 
CARDIOMYOPA
THY
ST ELEVATION
DILATED 
CARDIOMYO
PATHY
NONSURVIVOR
S. 
NO.
NAME AGE SEX COMPLAINTS
PROVISIONAL 
DIAGNOSIS
FINAL DIAGNOSIS
VOLUME 
RESUSCITATION
IONOTROPIC 
SUPPORT
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LATION
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OT
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RESULTS
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12 LEAD ECG CHEST XRAY
OUTCOME-
SURVIVOR / NON-
SURVIVOR
108 SOMNATH 8 YEARS MCH FEVER
VIRAL FEVER WITH 
THROMBOCYTOPENIA
VIRAL FEVER WITH 
THROMBOCYTOPENIA
YES NO NO NO 4 DAYS MEDICAL 0.002 NORMAL
NORMAL 
STUDY
NORMAL
RIGHT SIDED 
PLEURAL 
EFFUSION
SURVIVOR
109 SAARULATHA 11 YEARS FCH SNAKEBITE SNAKEBITE SNAKE BITE ENVENOMATION NO NO YES NA 5 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
110 ZOYA FATHIMA 2 MONTHS FCH FEVER,BREATHLESSNESS BRONCHOPNEUMONIA BRONCHOPNEUMONIA NO NO NO NA 3 DAYS MEDICAL 0.004 NORMAL
NORMAL 
STUDY
NORMAL
BRONCHOP
NEUMONIA
SURVIVOR
111 RAMYA 7 YEARS FCH FEVER
FEVER WITH 
THROMBOCYTOPENIA
FEVER WITH 
THROMBOCYTOPENIA
YES NO NO NA 4 DAYS MEDICAL 0.001 NORMAL
NORMAL 
STUDY
NORMAL NORMAL SURVIVOR
112 SUMAIYA BEGUM 2 MONTHS FCH FEVER,JAUNDICE
SEPTIC SHOCK/BILIARY 
ATRESIA INDUCED LIVER 
CIRRHOSIS
SEPTIC SHOCK/BILIARY 
ATRESIA INDUCED LIVER 
CIRRHOSIS
YES YES 1,4 YES YES 12 DAYS SURGICAL 0.022 NORMAL
NORMAL 
STUDY
NORMAL NORMAL NON SURVIVOR
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ABNORMAL ECG FINDINGS 
 
 
 
 
4 Months old baby with congenital hypothyroidism  
low QRS voltages in limb leads 
 
 
 
 Dilated cardiomyopathy in 3 year old male child. ECG showing conduction 
delay due to cardiodilatation. Low QRS complexes in limb leads. Discrepancy of 
QRS voltages with signs of hypertrophy in V4-6 and relatively low voltages in the 
limb leads.  
 
 
 
Pericardial effusion in a 4 months old boy with low voltage, tachycardia and 
electrical alternans. 
  
 
ABNORMAL ECHO FINDINGS 
 
 
 
 
Pericardial effusion in a 4 months old baby with congenital hypothyroidism 
 
 
 
 
 
Dilated cardiomyopathy and low LVEF (30%) in a 3 year old male child with 
viral myocarditis and cardiogenic shock 
